期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | CELL DEATH AND DIFFERENTIATION LetPub Score 9.0
50 ratings
Rate
Reputation 9.9 Influence 8.7 Speed 7.2 | ||||||||||||||||||||
期刊簡稱 | CELL DEATH DIFFER | ||||||||||||||||||||
ISSN | 1350-9047 | ||||||||||||||||||||
E-ISSN | 1476-5403 | ||||||||||||||||||||
h-index | 193 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 1.50%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | https://www.nature.com/cdd | ||||||||||||||||||||
在線稿件提交 | https://mts-cdd.nature.com/ | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Springer Nature | ||||||||||||||||||||
主題領域 | 生物 | ||||||||||||||||||||
出版國/地區 | ENGLAND | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 1997 | ||||||||||||||||||||
每年文章數 | 139每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 49.80% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1350-9047%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 3.0 month(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: About 80% | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
[CELL DEATH AND DIFFERENTIATION] 的評論 | 撰寫評論 |
作者: jessica chu 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-11-19 11:15:14 評論於 Just wanted to ask, was the link provided for redirection in the end? I also received suggestions to redirect, but it shows that the link is Redacted, do I need to wait or contact the editorial department?(0) 讚! | jessica chu |
作者: AKAPAN 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-30 15:17:52 評論於 Why am I always being rejected?(0) 讚! | AKAPAN |
作者: 奇颖殿下 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-27 20:58:48 評論於 After receiving the editor assigned, will there be another step of under review?(0) 讚! | 奇颖殿下 |
作者: 奇颖殿下 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-27 17:39:00 評論於 Is there a step of "under review" after the receiving editor is assigned?(0) 讚! | 奇颖殿下 |
作者: 奇颖殿下 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-27 15:25:16 評論於 Will there be a step of "under review" afterwards?(0) 讚! | 奇颖殿下 |
作者: 混元庚寅 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-18 13:35:21 評論於 It has been 80 days, the status changed from under consideration to blank and then back to under consideration. What's going on?(0) 讚! | 混元庚寅 |
作者: 断刀浩荡 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-10-10 18:08:02 評論於 Does the Western Union need the original strip?(0) 讚! | 断刀浩荡 |
作者: _darktempler 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-24 17:33:01 評論於 Direction of protein modification, lactylation modification, major revision was given in the first review, with two reviewers, one of whom had no major comments and thought that the research seemed to have sufficiently proved the author's point, and provided two minor comments, while the other reviewer provided some suggestions. It was sent back for revisions for 2 months, waiting for the results of the second review. I hope it can be faster and also wish for good luck, this manuscript has been rejected several times, my heart is truly tired.(0) 讚! | _darktempler |
作者: 极乐彩霞 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-23 14:18:15 評論於 May I ask what you mean by "后续" in English?(0) 讚! | 极乐彩霞 |
作者: 夏易baby 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-14 13:56:46 評論於 When will the submission be assigned an editor?(0) 讚! | 夏易baby |
作者: 夏易baby 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-14 11:57:57 評論於 I have also received it, replied to the email, but the editor has not been assigned yet.(0) 讚! | 夏易baby |
作者: 夏易baby 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-13 14:26:46 評論於 When will everyone be assigned editors?(0) 讚! | 夏易baby |
作者: 夏易baby 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-11 18:03:26 評論於 How are things now?(0) 讚! | 夏易baby |
作者: XLSL 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-30 16:01:10 評論於 I also have been given 4 months for major repairs, some experiments cannot be carried out. How are you doing now?(0) 讚! | XLSL |
作者: 削月莆泽 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-27 13:30:45 評論於 May I ask if you were rejected later on? My submission has been pending for 7 days now... not looking too promising, right?(0) 讚! | 削月莆泽 |
作者: Adelaide Lawson 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-18 14:24:45 評論於 The reviewers have completed the review of the manuscript and have submitted their comments to the editorial department. Please check your email for updates.(0) 讚! | Adelaide Lawson |
作者: 迎珊小可爱 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-14 08:28:08 評論於 On the first day of submission, it is under consideration, and a decision is made on the eighth day. What does this mean? Has it been rejected?(0) 讚! | 迎珊小可爱 |
作者: 颂歌卢卡斯 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-11 23:42:28 評論於 Research focus: Mechanisms of tumor metastasis Experience sharing: After submitting the manuscript, what should we do if co-authors did not receive the email notification? Can they still receive it later?(0) 讚! | 颂歌卢卡斯 |
作者: 小海宾吖 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-31 20:45:33 評論於 Research focus: Tumor experience sharing: Big CDD requires a clear molecular mechanism, which is highly recognized in the field of oncology. Editors are very fond of p53, ubiquitination, and various new types of cell death-related work. Worth a try.(1) 讚! | 小海宾吖 |
作者: 也不容易哦 領域: 生物学 審稿時間: 2.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-15 19:09:57 評論於 The submission was made on June 10, 2024, and there has been no response so far.(0) 讚! | 也不容易哦 |
作者: 王二哥 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2024-07-09 08:01:33 評論於 Submission on 2024.07.03, shown as Under Consideration immediately after submission. On 2024.07.04, Research Square displayed Submission checks complete. On 2024.07.05, received an email recommending Receiving Editor, even though Receiving Editor was selected on the submission system, still received this email. Receiving Editor replied from the Editorial Board on the official website, possibly related to the direction. Decision Made on 2024.07.06 (Friday), felt like it was going to be rejected. On 2024.07.08, Reject, suggested to submit to Small CDD. The article was previously submitted to Advance Science, sent for review, received two reviews, one agreed to major revisions, and one rejected, Editor directly rejected it. Submission to Big CDD was almost instantly rejected, not sent for review. Big CDD publishes articles mainly focused on tumors and ubiquitination mechanisms. Overall quality is high, with good reputation and extremely fast review speed. Due to the lower number of published articles, around 100 per year, it is considered small and refined, unlike some domestic journals that rely on reviews to forcibly boost their IF, the review process is stricter and more challenging compared to Advance Science.(1) 讚! | 王二哥 |
作者: 璧射初兰 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-04 18:21:26 評論於 It seems to have stopped now, Nature is on strike altogether and the situation remains unchanged.(0) 讚! | 璧射初兰 |
作者: 碧水力行 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-26 15:44:09 評論於 May I ask if it's possible?(0) 讚! | 碧水力行 |
作者: 削月以松 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-21 20:59:27 評論於 Almost.(0) 讚! | 削月以松 |
作者: Micheal-wang 領域: 生物学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-19 18:49:37 評論於 May I ask how to proceed next?(0) 讚! | Micheal-wang |
首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 |
Contact us